Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY2A | P04746 | 9/20 | 0.45 |
| ▸ | GAA | P10253 | 4/20 | 0.45 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.45 |
| ▸ | MGAM | O43451 | 2/20 | 0.45 |
| ▸ | SI | P14410 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22105653 | 0.89 | L3MBTL1 (0.43) | AMY2AGAAAMY1AMGAMSI | |
| SCHEMBL23810860 | 0.82 | L3MBTL1 (0.36) | GAAALDH1A1LGALS8LGALS3L3MBTL1 | |
| SCHEMBL19414226 | 0.82 | L3MBTL1 (0.36) | GAAALDH1A1LGALS8LGALS3L3MBTL1 | |
| SCHEMBL15947389 | 0.81 | AMY2A (0.57) | AMY2AGAAAMY1AMGAMSI | |
| SCHEMBL12090762 | 0.81 | AMY2A (0.57) | AMY2AGAAAMY1AMGAMSI | |
| Maltose SCHEMBL6242461 | 0.81 | LGALS8 (0.58) | AMY2AGAAAMY1AMGAMSI | |
| SCHEMBL18671676 | 0.81 | AMY2A (0.57) | AMY2AGAAAMY1AMGAMSI | |
| Cellobiose SCHEMBL24202679 | 0.81 | LGALS8 (0.61) | AMY2AGAAAMY1AMGAMSI | |
| Maltotriose SCHEMBL23467170 | 0.81 | LGALS8 (0.61) | AMY2AGAAAMY1AMGAMSI | |
| Cellobiose SCHEMBL23752618 | 0.81 | LGALS8 (0.61) | AMY2AGAAAMY1AMGAMSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912599-B2 | Enzymatic purification of water | PHAREM BIOTECH AB (SE) | 2024-02-27 | — | — | US | disclosed |
| US-11814795-B2 | Coating for recyclable paper | JL DARLING LLC (US) | 2023-11-14 | — | — | US | disclosed |
| US-11149133-B2 | Cellulose resin composition, molded body and product using same | NEC CORPORATION (JP) | 2021-10-19 | — | — | US | disclosed |
| US-20210156060-A1 | LOW BASIS WEIGHT FLAME RETARDANT SCRIM, ARTICLES, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2021-05-27 | — | — | US | disclosed |
| US-10968283-B2 | Method for producing functionalized nanocrystalline cellulose and functionalized nanocrystalline cellulose thereby produced | ANOMERA INC. (CA) | 2021-04-06 | — | — | US | disclosed |
| US-20200189947-A1 | ENZYMATIC PURIFICATION OF WATER | PHAREM BIOTECH AB (SE) | 2020-06-18 | — | — | US | disclosed |
| US-20200071736-A1 | METHOD FOR THE ENZYMATIC SACCHARIFICATION OF A POLYSACCHARIDE | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2020-03-05 | — | — | US | disclosed |
| US-20190169402-A1 | CELLULOSE RESIN COMPOSITION, MOLDED BODY AND PRODUCT USING SAME | NEC CORPORATION (JP) | 2019-06-06 | — | — | US | disclosed |
| US-9976071-B2 | Enhanced oil recovery processes | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-05-22 | — | — | US | disclosed |
| US-20170260298-A1 | METHOD FOR PRODUCING FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE AND FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE THEREBY PRODUCED | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2017-09-14 | — | — | US | disclosed |
| US-20170044884-A1 | ENHANCED OIL RECOVERY PROCESSES | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10968283-B2 | Method for producing functionalized nanocrystalline cellulose and functionalized nanocrystalline cellulose thereby produced | DCXR, SOD1, NOX5 | AMY2A 982/4885GAA 596/4885AMY1A 841/4885 |
| US-20170260298-A1 | METHOD FOR PRODUCING FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE AND FUNCTIONALIZED NANOCRYSTALLINE CELLULOSE THEREBY PRODUCED | DCXR, SOD1, NOX5 | AMY2A 982/4885GAA 596/4885AMY1A 841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.